<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7-vaccines-08-00036">
 <label>7.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Weber</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Rutala</surname>
    <given-names>W.A.</given-names>
   </name>
   <name>
    <surname>Fischer</surname>
    <given-names>W.A.</given-names>
   </name>
   <name>
    <surname>Kanamori</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sickbert-Bennett</surname>
    <given-names>E.E.</given-names>
   </name>
  </person-group>
  <article-title>Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)</article-title>
  <source>Am. J. Infect. Control.</source>
  <year>2016</year>
  <volume>44</volume>
  <fpage>e91</fpage>
  <lpage>e100</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ajic.2015.11.018</pub-id>
 </element-citation>
</ref>
